Analysts Predict Significant Upside for JMEE and Holdings

Analysts foresee a 24.83% upside for JPMorgan Market Expansion Enhanced Equity ETF (JMEE), trading at $56.85. Notably, TransMedics (TMDX), Minerals Technologies (MTX), and Bristow Group (VTOL) show strong potential with upsides exceeding 46%.

Date: 05-03-2025

AI Rating: 7

**Earnings Outlook**: The report highlights that the JPMorgan Market Expansion Enhanced Equity ETF (JMEE) is currently trading at $56.85, while analysts have an average target price of $70.97, which implies a significant 24.83% upside potential. This positive outlook is supported by the notable future price targets of JMEE's underlying holdings.

**Individual Holdings Analysis**: Three specific stocks within JMEE exhibit considerable upside potential: TransMedics Group Inc (TMDX), Minerals Technologies, Inc. (MTX), and Bristow Group Inc (VTOL). TMDX has a recent share price of $69.11, which has a target price of $102.00, presenting a robust upside of 47.59%. Similarly, MTX’s share price is $66.53, with a target of $98.00, indicating a 47.30% increase possibility. Lastly, VTOL’s recent price of $33.15 has a target price of $48.50, reflecting a 46.30% upside as well.

**Market Sentiment**: The overall sentiment reflected in the analyst target prices suggests optimism about the future performance of these stocks. However, the report raises questions about whether these targets are justified, considering recent market trends and developments which require further investor scrutiny.

Stocks: JMEE TMDX MTX VTOL